- Home
- MSW vs ALGS Comparison
MSW vs ALGS Comparison
Compare MSW & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSW
- ALGS
- Stock Information
- Founded
- MSW 2012
- ALGS 2018
- Country
- MSW Hong Kong
- ALGS United States
- Employees
- MSW N/A
- ALGS N/A
- Industry
- MSW
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- MSW
- ALGS Health Care
- Exchange
- MSW NYSE
- ALGS Nasdaq
- Market Cap
- MSW 62.8M
- ALGS 50.4M
- IPO Year
- MSW 2024
- ALGS 2020
- Fundamental
- Price
- MSW N/A
- ALGS $7.84
- Analyst Decision
- MSW
- ALGS Strong Buy
- Analyst Count
- MSW 0
- ALGS 1
- Target Price
- MSW N/A
- ALGS $70.00
- AVG Volume (30 Days)
- MSW 137.2K
- ALGS 125.8K
- Earning Date
- MSW 08-25-2025
- ALGS 08-05-2025
- Dividend Yield
- MSW N/A
- ALGS N/A
- EPS Growth
- MSW 18.78
- ALGS N/A
- EPS
- MSW 0.20
- ALGS N/A
- Revenue
- MSW $31,769,612.00
- ALGS $3,270,000.00
- Revenue This Year
- MSW N/A
- ALGS N/A
- Revenue Next Year
- MSW N/A
- ALGS $51.55
- P/E Ratio
- MSW $22.26
- ALGS N/A
- Revenue Growth
- MSW 30.91
- ALGS N/A
- 52 Week Low
- MSW $2.12
- ALGS $3.76
- 52 Week High
- MSW $10.58
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- MSW N/A
- ALGS 57.02
- Support Level
- MSW N/A
- ALGS $6.82
- Resistance Level
- MSW N/A
- ALGS $8.66
- Average True Range (ATR)
- MSW 0.00
- ALGS 0.76
- MACD
- MSW 0.00
- ALGS -0.06
- Stochastic Oscillator
- MSW 0.00
- ALGS 55.49
About MSW MING SHING GROUP HOLDINGS LIMITED
Ming Shing Group Holdings Ltd is a holding company, which is primarily operated through its indirectly wholly-owned Hong Kong Operating Subsidiaries, MS (HK) Engineering Limited and MS Engineering Co., Limited. It is engaged in wet trades works, such as plastering works, tile laying works, brick laying works, floor screeding works and marble works. the company is mainly engaged in private-sector projects in Hong Kong. Its private sector projects mainly involve private residential developments and commercial developments. The project owners of its private sector projects are generally property developers, and its customers are generally main contractors and wet trades work subcontractors engaged under such projects.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.